Marta Spreafico

<i>CYP2C9</i> genotypes and dose requirements during the induction phase of oral anticoagulant therapy

Flora Peyvandi, Marta Spreafico, Simona Maria Siboni et al. · Clinical Pharmacology & Therapeutics · 2004 · 101 citations · Full text

High Serum Levels of HDV RNA Are Predictors of Cirrhosis and Liver Cancer in Patients with Chronic Hepatitis Delta

R. Romeo, Barbara Foglieni, Giovanni Casazza et al. · PLoS ONE · 2014 · 93 citations · Full text

Hepatitis Delta Virus, Hepatitis B, Pathology +19

Genotype-phenotype correlation in combined deficiency of factor V and factor VIII

Bin Zhang, Marta Spreafico, Chunlei Zheng et al. · Blood · 2008 · 81 citations · Full text

Influence of 9p21.3 Genetic Variants on Clinical and Angiographic Outcomes in Early-Onset Myocardial Infarction

Diego Ardissino, Carlo Berzuini, Piera Angelica Merlini et al. · Journal of the American College of Cardiology · 2011 · 80 citations

Genetic Variants, Angiographic Outcomes, Cardiovascular Disease +14

The association of factor V Leiden with myocardial infarction is replicated in 1880 patients with premature disease

Pier Mannuccio Mannucci, Rosanna Asselta, Stefano Duga et al. · Journal of Thrombosis and Haemostasis · 2010 · 62 citations

Thrombosis, Heart Failure, Vascular Disease +14